These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 4640318)

  • 1. Pure red cell anemia: immunosuppressive treatment.
    Böttiger LE; Rausing A
    Ann Intern Med; 1972 Apr; 76(4):593-7. PubMed ID: 4640318
    [No Abstract]   [Full Text] [Related]  

  • 2. Pure red-cell anaemia with pro-erythroblast maturation arrest.
    Wranne L; Bonnevier JO; Killander A; Killander J
    Scand J Haematol; 1970; 7(2):73-5. PubMed ID: 5450689
    [No Abstract]   [Full Text] [Related]  

  • 3. [A case of childhood erythroblastopenia with late onset].
    Fondu P; Mandelbaum IM; Stryckmans PA; Delalieux G; Heyder-Bruckner C; Loeb H
    Nouv Rev Fr Hematol; 1972; 12(1):5-14. PubMed ID: 4262132
    [No Abstract]   [Full Text] [Related]  

  • 4. Remission of pure red cell aplasia following oxymetholone therapy.
    Chang JC; Slutzker B; Lindsay N
    Am J Med Sci; 1978; 275(3):345-51. PubMed ID: 686041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Immunosuppressive therapy in pure red cell aplasia].
    Bruntsch U; Gallmeier WM; Burkhardt R; Schmidt CG
    Dtsch Med Wochenschr; 1975 Jan; 100(3):102-6. PubMed ID: 1078653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from aplastic anemia after treatment with cyclophosphamide.
    Baran DT; Griner PF; Klemperer MR
    N Engl J Med; 1976 Dec; 295(27):1522-3. PubMed ID: 995159
    [No Abstract]   [Full Text] [Related]  

  • 7. [The immunosuppressive treatment of pure erythroblastopenia, using cyclophosphamide and antilymphocyte globulins].
    Marmont A
    Minerva Med; 1975 Jul; 66(51):2490-508. PubMed ID: 1153111
    [No Abstract]   [Full Text] [Related]  

  • 8. Congenital erythroid hypoplastic anaemia in mother and daughter.
    Hamilton PJ; Dawson AA; Galloway WH
    Arch Dis Child; 1974 Jan; 49(1):71-3. PubMed ID: 4818099
    [No Abstract]   [Full Text] [Related]  

  • 9. HEMPAS.
    Br Med J; 1973 Aug; 3(5876):370. PubMed ID: 4730186
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic considerations in acquired pure red cell aplasia in adults.
    Kramer S; Kaplan L; Metz J
    S Afr Med J; 1967 Aug; 41(32):804-7. PubMed ID: 6051100
    [No Abstract]   [Full Text] [Related]  

  • 11. Bone-marrow failure: diagnosis and treatment.
    Gordon-Smith EC
    Br J Haematol; 1972 Sep; 23():Suppl:167-75. PubMed ID: 4647405
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunosuppressive treatment of aplastic anemia--a case report].
    Jameson S
    Nord Med; 1970 Dec; 84(49):1567. PubMed ID: 5488572
    [No Abstract]   [Full Text] [Related]  

  • 13. Pure red cell aplasia: three cases responding to immunosuppression.
    Gill PJ; Amare M; Larsen WE
    Am J Med Sci; 1977; 273(2):213-9. PubMed ID: 860735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aetiocholanolone and prednisolone therapy in patients with severe bone-marrow failure.
    Besa EC; Wolff SM; Dale DC; Gardner FH
    Lancet; 1977 Apr; 1(8014):728-30. PubMed ID: 66522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prognosis and therapy of aplastic anemia].
    Benöhr HC
    Fortschr Med; 1974 Aug; 92(22):887-90. PubMed ID: 4420648
    [No Abstract]   [Full Text] [Related]  

  • 16. Pyridoxine-responsive anemia: influence of tryptophan on pyridoxine responsiveness.
    Horrigan DL
    Blood; 1973 Aug; 42(2):187-93. PubMed ID: 4793110
    [No Abstract]   [Full Text] [Related]  

  • 17. Erythrokinetics in the treatment of aplastic anemia with methandrostenolone.
    Reynafarje C; Faura J
    Arch Intern Med; 1967 Dec; 120(6):654-60. PubMed ID: 6058400
    [No Abstract]   [Full Text] [Related]  

  • 18. Successful immunosuppressive treatment of erythroid aplasia appearing after thymectomy.
    Safdar SH; Krantz SB; Brown EB
    Br J Haematol; 1970 Oct; 19(4):435-43. PubMed ID: 5312272
    [No Abstract]   [Full Text] [Related]  

  • 19. Production, utilization and excretion of erythropoietin. I. Chronic anemias. II. Aplastic crisis. 3. Erythropoietic effects of normal plasma.
    Hammond D; Shore N; Movassaghi N
    Ann N Y Acad Sci; 1968 Mar; 149(1):516-27. PubMed ID: 5240745
    [No Abstract]   [Full Text] [Related]  

  • 20. Oxymetholone treatment in hypoproliferative anaemia. I. Frequency of response.
    Skårberg KO; Engstedt L; Jameson S; Killander A; Lundh B; Pers B; Reizenstein P; Udén AM; Wadman B
    Acta Haematol; 1973; 49(6):321-30. PubMed ID: 4200617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.